{
  "$type": "site.standard.document",
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/02/04/novo-obesity-trump-psychedelics-fda-vouchers-switzerland/?utm_campaign=rss",
  "publishedAt": "2026-02-04T14:09:13.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall meeting",
  "title": "STAT+: Pharmalittle: We’re reading about worries over FDA voucher program, a new U.S. Novo exec, and more",
  "updatedAt": "2026-02-04T14:09:18.000Z"
}